CFN Exclusive Interview with Rachael Maddison, Founder and CEO of StrainConnect
December 7th, 2018
The new world of legal cannabis can be overwhelming, particularly for those who have little to no experience. StrainConnect is an easy-to-use app that helps users select the perfect cannabis products for their desired outcomes, utilizing lab data from producers combined with self-reported questionnaires from individual consumers. The revolutionary platform is already changing the lives of patients across the US through its CBD database and will be expanding to THC markets in early 2019.
CFN Media spoke with StrainConnect Founder and CEO Rachael Maddison at the recent Canna Newswire Wake and Bake Media Showcase in Las Vegas to learn more about the company’s disruptive tech and how they plan to revolutionize the way the world shops for cannabis.
CFN: What is your background and how did you develop StrainConnect?
Rachael Maddison: I’m a UX designer and Information Architect by trade, and I founded StrainConnect based on a personal need. I had sciatica and a separated shoulder after having my two children. After the traditional medical methods failed me, I looked to cannabis. Going through the product search process as a new “canna-curious” consumer took me almost 8-months to find the right products for me and I spent almost $2400 on products I’d never use again. Beyond being time-consuming and expensive, it felt isolating, not only because of the stigma but every other resource or recommendation I received never considered all of me. So, I knew with my technical and customer service-oriented background I’d be able to build a team to create a quick and handy resource to help consumers feel more confident in their CBD & cannabis purchases.
Our technology connects the bioscience of the plant and the bioscience of the consumer. We use updated product labs that include not only cannabinoids but also the terpene profiling. Our machine-learning proprietary algorithm then matches those labs to a pinpointed questionnaire that asks the consumer about their ailments, how they want to feel, and then we also touch on who they are and their personality characteristics, providing them with a very focused list of recommended products, all within 3-minutes or less!
We then direct the patient to exactly where to purchase the product. Currently, with our CBD recommendations, individuals across the US can purchase their CBD products online, through our brand affiliates, to have products delivered right to their door. In the coming months, we’ll open our THC recommendations in California, in which the consumer will have the option to do an in-store pickup at a dispensary, or have their products delivered to their door (if it’s allowed within their geolocation).
CFN: What sets StrainConnect apart from potential competitors in this space?
RM: Besides personalizing the product recommendations, we’re vetting the brands. Every brand must apply to be a part of our platform. Not only are we vetting their third-party lab results, but we’re also vetting the laboratories they’ve had their product tested at. We also consider what their current marketing is to ensure they’re not misleading the consumer. For example, if the brand states, “Our products are full spectrum isolate.” Well…this obviously doesn’t make any sense – the product can be an isolate, or it can be full spectrum – but it cannot be both. But consumers that are new to CBD and cannabis don’t know that.
CFN: Why is that “personalization of the product” so integral for patient success?
RM: You see, everybody responds differently. For example, you and I can both have the same ailment and desired effect, but fundamentally if you’re energetic and I’m low in energy, we’re going to have very different responses to the same product.
Now consider all of the different “selfs” or different times you may need a new product. For example, you’re most likely going to need a different product while you’re with your children, or if you’re at work and want to feel focused, or if you need assistance with sleep, or maybe want something to enhance intimacy…all of these are different profiles you can save within the StrainConnect app. Most importantly, product labs are constantly changing, so all of those product recommendations are also going to change over time.
CFN: What are you looking forward to as a company in 2019?
RM: Generally speaking, the CBD movement is really important for the cannabis industry as a whole. For StrainConnect, we’re focused on closing our pre-seed round so we can then focus on THC recommendations, which is a much-needed resource. We’re also looking to help Pros in the industry make better product recommendations to their customers, along with some other exciting things I can’t yet share!
CFN: Why should people consider investing at this stage and what makes a perfect business partner?
RM: StrainConnect is beyond “green wave”…We see a blue ocean opportunity for StrainConnect to lead a movement of personalization, standardization, and education. We’re capitalizing on that movement, and now is the only time for investors to get in on the ground floor.
To learn more about cannabis tech, sign up for our free newsletter using the form to the right.
Follow Us on Social Media
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.